Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea R Florl

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Genes, Chromosomes & Cancer|April 16, 2003
Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cellsAndrea R Florl, Wolfgang A Schulz
Archives of Toxicology|February 7, 2008
Chromosomal instability in bladder cancerAndrea R Florl, Wolfgang A Schulz
International Journal of Cancer|November 20, 2004
Multiple mechanisms downregulate CDKN1C in human bladder cancerMichèle J Hoffmann, Andrea R Florl, Hans-Helge Seifert, et al.
Oncology Research|November 3, 2005
Hypomethylation of the XIST gene promoter in prostate cancerThilo Laner, Wolfgang A Schulz, Rainer Engers, et al.
Cancer Biology & Therapy|June 16, 2006
DNA methylation alterations in urothelial carcinomaAnne Neuhausen, Andrea R Florl, Marc-Oliver Grimm, et al.
Genes, Chromosomes & Cancer|October 21, 2004
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell linesSascha Raschke, Vera Balz, Thomas Efferth, et al.
Mutation Research|October 12, 2007
Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cellsFrank Windhofer, Sabine Krause, Christiane Hader, et al.
International Journal of Cancer|September 23, 2008
Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancerOlusola Y Dokun, Andrea R Florl, Hans-Helge Seifert, et al.
Human Mutation|May 18, 2004
Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancerBeate Betz, Andrea R Florl, Hans-Helge Seifert, et al.
European Urology|November 29, 2005
Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stageRoland Kindich, Andrea R Florl, Jörn Kamradt, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Genes, Chromosomes & Cancer|April 16, 2003
Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cellsAndrea R Florl, Wolfgang A Schulz
Archives of Toxicology|February 7, 2008
Chromosomal instability in bladder cancerAndrea R Florl, Wolfgang A Schulz
International Journal of Cancer|November 20, 2004
Multiple mechanisms downregulate CDKN1C in human bladder cancerMichèle J Hoffmann, Andrea R Florl, Hans-Helge Seifert, et al.
Oncology Research|November 3, 2005
Hypomethylation of the XIST gene promoter in prostate cancerThilo Laner, Wolfgang A Schulz, Rainer Engers, et al.
Cancer Biology & Therapy|June 16, 2006
DNA methylation alterations in urothelial carcinomaAnne Neuhausen, Andrea R Florl, Marc-Oliver Grimm, et al.
Genes, Chromosomes & Cancer|October 21, 2004
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell linesSascha Raschke, Vera Balz, Thomas Efferth, et al.
Mutation Research|October 12, 2007
Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cellsFrank Windhofer, Sabine Krause, Christiane Hader, et al.
International Journal of Cancer|September 23, 2008
Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancerOlusola Y Dokun, Andrea R Florl, Hans-Helge Seifert, et al.
Human Mutation|May 18, 2004
Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancerBeate Betz, Andrea R Florl, Hans-Helge Seifert, et al.
European Urology|November 29, 2005
Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stageRoland Kindich, Andrea R Florl, Jörn Kamradt, et al.
Pageof 3